🚨 A reminder,
The deadline for our travel awards is fast approaching. Submit your application by May 5th to be considered. Travel awards will be up to €750 to support workshop attendance. #EBPS2026

Premature aging in serious mental illness Neuropsychopharmacology - Premature aging in serious mental illness

This review examines evidence that serious mental illnesses are associated with accelerated biological aging, highlighting the consequences of greater symptom severity, poorer treatment response, and increased medical comorbidity

Mitochondrial dysfunction in PTSD: A mechanism to understand trauma susceptibility? - Psychopharmacology Rationale and Objectives Post-Traumatic Stress Disorder (PTSD) is a complex mental health condition that arises following exposure to traumatic events. Converging evidence suggests mitochondrial dysfunction and brain energy metabolism impairment in its pathophysiology. Thus, examining mitochondrial data from both preclinical and experimental medicine studies may help us to have a deeper understanding of the pathophysiological mechanisms underlying PTSD. Methods Using PubMed, Scopus and Web of Science online databases, we conducted a search for peer-reviewed manuscripts targeting both mitochondrial-related activity and PTSD. Our search yielded 43 studies in total, including 29 in rodent models and 15 clinical studies. Results Preclinical studies reported a decrease in energy metabolism with a reduction in adenosine triphosphate (ATP) level, upregulation of genes associated with ATP synthesis, impairment of the glycolytic pathway, citric acid cycle and oxidative phosphorylation pathways and increased oxidative stress and neuronal apoptosis in the brain, or systemically. In the clinical setting, studies identified 1108 participants with PTSD and 312 with partial PTSD, with these individuals showing alterations in energy production, mitochondrial DNA copy number (mtDNAcn) and elevated oxidative stress. Risperidone and AC-5216—a selective ligand for TSPO—emerged as potential treatments. Conclusion Our synthesis of the published findings indicates a notable overlap between results from both animal models and humans which could show a potential usage of mitochondrial-related targets as biomarkers or for drug discovery. Additionally, these results highlight the need for future research in describing whether mitochondrial dysfunction is a cause or a symptom of PTSD.

Great to see Felippe Espinelli Amorim’s (not yet on BlueSky) and @charlotte-rye.bsky.social’s meta-analysis on mitochondrial dysfunction in PTSD out in @psychopharmacology.bsky.social 👏🏻
link.springer.com/article/10.1...

New training opportunity for early career researchers based in Africa!
Participants will gain experience using different brain modalities to explore unique #neuroscience questions relevant to the region.

Apply by 30 Apr👇
https://ow.ly/LEfB50YAvEK

#IBROinAfrica

Stipends of up to 750 EUR are now available for students located in Europe to attend: Hands-on course: Human stem cell derived neuronal networks in health and disease

🌟 FENS/IBRO-PERC stipends available for short courses organised by the FENS Schools Network:

🔷 Hands-on Course: Human Stem Cell Derived Neuronal Networks in Health and Disease
🌍️ Nijmegen, the Netherlands
🗓️ 21-28 August 2026
🔗 buff.ly/QYuhwgl

@ibroorg.bsky.social

We are accepting Travel Award applications for #EBPS2026. We are especially interested in applications from trainees from underrepresented backgrounds. All details can be found on the event website ebps2026.azuleon.org/information#...

Registration is now open for the EBPS 2026 workshop! Learn more about the workshop and speakers at the event website ebps2026.azuleon.org

Check out our latest research drop! We show BLA dopamine signaling encodes the emotional weight of sensory transitions, but not the associative strength or value of stimuli. These signals dynamically rescale when the learning context changes: "this matters most!" www.biorxiv.org/content/10.1...

The first time you start a research lab, there’s no manual.

So I made one.

A practical toolkit for postdocs and early-career faculty launching their first lab: hiring, startup planning, collaborations, and building a sustainable research program.

zenodo.org/records/1888...

#research #postdoc

We are pleased to announce the keynote and confirmed speakers for our 2026 workshop "Integrating new perspectives on punishment for learning, decision making and psychopathology". More information can be found at ebps2026.azuleon.org. Registration opens March 5th 2026 #EBPS2026

Psychopharmacology Psychopharmacology is an international journal discussing the mechanisms by which drugs influence behavior. Publishes research and reviews on the impact of ...

The special issue in Psychopharmacology from EBPS2023 is now out as a complete collection. You can find the papers all here link.springer.com/journal/213/...

Happy International Day of Women and Girls in Science, featuring just some of the amazing women who make our society great across the executive, full, IDEA and communications committees #InternationalDayOfWomenAndGirlsInScience

Call for papers for a Special Issue on Big Data, AI and Machine Learning in Addiction research, guest edited by @flagel-lab.bsky.social and @gavanm.bsky.social in @psychopharmacology.bsky.social link.springer.com/collections/...

NEW Psychopharmacology Special Issue derived from the #EBPS2023 biennial in Mannheim. Focused on Stress, Trauma and Cannabinoids!

a cat wearing glasses is sitting on top of an open book on a table . ALT: a cat wearing glasses is sitting on top of an open book on a table .

Dear EBPS community, we have published our latest newsletter with up to date goings on, and future events. We have included new content, including a "Perspectives" and "Industry Updates" piece for your interest. You can download the newsletter here drive.google.com/file/d/1f8t_...

🌟 Only 6 months until #FENS2026!

Soon, the #neuroscience community will come together to exchange ideas and explore the latest breakthroughs in neuroscience. 🧠

📍 Barcelona, Spain
🗓️ 6–10 July 2026

👉 Learn more and join us in #Barcelona: fensforum.org

#FENS #FENSForum #NeuroscienceConference

🚨 The deadline for the #FENS2026 call for abstracts, travel grants and registrations is approaching quickly!

Don’t miss your chance to participate in the #FENSForum and connect with the global #neuroscience community. 🧠

🗓️ Deadline: 27 January 2026
👉 buff.ly/klWSVOg

🚨Meeting Announcement🚨
Our 2026 workshop will be held in Amsterdam, NL.
August 25th & 26th.
The workshop will focus on the influence of punishment on learning, decision making and psychopathology.
Organised by Nathan Marchant, Heidi Lesscher, and @bertush.bsky.social. More information to follow!

European Behavioural Pharmacology Society (EBPS) | LinkedIn European Behavioural Pharmacology Society (EBPS) | 243 followers on LinkedIn. The European Behavioural Pharmacology Society proudly acknowledges its origins, as indicated by its name, but it should no...

For those members leaning toward other platforms, we have an account on LinkedIn also. This was set up some time ago, but we are going to begin posting there as we do on our other sites so give it a follow www.linkedin.com/company/eurb...

Survey from FENS-Kavli Scholars for PIs and group leaders nam04.safelinks.protection.outlook.com?url=https%3A...

We’re testing whether low-dose THC given before key Prolonged Exposure sessions can boost fear extinction, engage vmPFC–hippocampal circuits, and improve PTSD outcomes in a randomized, double-blind trial.

doi.org/10.1016/j.cc...

#PTSD #THC #ExposureTherapy #ClinicalTrials

JAMA review, published Nov 26, 2025, on the therapeutic use of cannabis and cannabinoids. Figure 1 details the pharmacology of cannabis compounds including Δ9-tetrahydrocannabinol (Δ9-THC), Δ8-THC and Cannabidiol (CBD).

Approximately 27% of adults in the US and Canada report having ever used #cannabis for medical purposes.

This Review summarizes current evidence about the therapeutic use of cannabis and #cannabinoids in adults. ja.ma/49C7ILj

a penguin is sticking his head out of a hole next to a job application ALT: a penguin is sticking his head out of a hole next to a job application

✨PhD position✨
Check out this exciting funded PhD opportunity to assess the efficacy of the antipsychotic drug Cobenfy on cocaine-use disorder with Morgan Thomsen in Denmark. www.regionh.dk/job/s%C3%B8g...

✨Postdoc Position✨
See the details for this cool postdoc position at @kingscollegelondon.bsky.social exploring THC influences on paranoia in healthy and treatment seeking individuals my.corehr.com/pls/kclrecru...

Assessment of Visual Function in Mice Using Light/Dark Box and Multi-Feature Machine Learning www.biorxiv.org/content/10.1101/2025.11....

a drag queen is standing in front of a pink brick wall wearing a black dress and sunglasses . ALT: a drag queen is standing in front of a pink brick wall wearing a black dress and sunglasses .

Want to keep updated on the latest events and updates at EBPS? You can read our latest newsletter here
drive.google.com/file/d/1QRdk...

What a perfect ending of #EBPS2025 super proud that I was the chair of this wonderful panel presenting their beautiful work on acute and chronic #cannabis effects. Excellent work @connorhaggarty.bsky.social @zivacooper.bsky.social Amir Englund & Lukas Eggeneberger 🤩

It's been fun. Thanks for hosting us, beautiful Almería, and thanks to everyone at #EBPS2025 for making it a fantastic meeting. Hoping everyone has safe and easy travels. 🤞 See you at #EBPS2027 in Cork!

Catch IBRO President-Elect, Shubha Tole, at the 2025 Brain Days, part of the Science Summit at #UNGA80

🗓 26 Sep 2025 | 14:30–15:10
📢 Discover more: buff.ly/4bEuUMF

@braincouncil.eu

A Two-Phase, Dose-Ranging, Placebo-Controlled Study of the Safety and Preliminary Test of Acute Effects of Oral Δ8-Tetrahydrocannabivarin in Healthy Participants | Cannabis and Cannabinoid Research Introduction: Tetrahydrocannabivarin (THCV) is an understudied cannabinoid that appears to have effects that vary as a function of dose. No human study has evaluated the safety and nature of effects…

🧠 Study published in Cannabis and Cannabinoid Research suggests THCV may improve sustained attention and is well tolerated in healthy adults.

Promising early evidence for therapeutic uses in attention disorders.
www.liebertpub.com/doi/10.1089/...